In 2023, the total number of 10% top-cited scientific publications in Endocrinology, Diabetes, and Metabolism in the US stood at 252 publications. From 2024 to 2028, forecasts indicate a steady and slight annual increase, with the value expected to reach 252.66 by 2028. This depicts a negligible year-on-year percentage change, signaling stagnation rather than significant growth or decline. The Compound Annual Growth Rate (CAGR) from 2024-2028 suggests an almost flat trend. The consistent projections highlight stability, yet little dynamism in terms of innovation or research breakthroughs.

Future trends to watch for include:

Emerging research areas within endocrinology spurring potential increases in publication citations.
Policy changes impacting research funding and collaboration in the fields of diabetes and metabolism.
Technological advancements and their integration into research methodologies driving future changes.